A rare malignant mesothelial neoplasm that usually involves both the ovarian surface and the ovarian stroma. In most cases there is bilateral ovarian involvement.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
The limited documentation surrounding ovarian malignant mesothelioma is largely due to its extreme rarity, which affects fewer than 200 people per year worldwide. This rarity makes it challenging to conduct systematic clinical studies and gather comprehensive clinical data. As a result, the understanding of its clinical features and genetic basis is still evolving.
To navigate ovarian malignant mesothelioma, consider seeking a specialist in gynecologic oncology or a medical oncologist with experience in rare tumors. Engaging with clinical trials may provide access to innovative treatments; check the ClinicalTrials.gov link provided for options. Although there are currently no patient organizations identified for this condition, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org can offer support and information on rare diseases.
There are currently 34 active clinical trials investigating various treatments for ovarian malignant mesothelioma. Notable FDA-approved treatments include nivolumab and ipilimumab, while several orphan drugs are in development. For more information on ongoing trials, you can visit ClinicalTrials.gov at https://clinicaltrials.gov/search?cond=ovarian%20malignant%20mesothelioma.
Actionable guidance for navigating care for ovarian malignant mesothelioma
To navigate ovarian malignant mesothelioma, consider seeking a specialist in gynecologic oncology or a medical oncologist with experience in rare tumors. Engaging with clinical trials may provide access to innovative treatments; check the ClinicalTrials.gov link provided for options. Although there are currently no patient organizations identified for this condition, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org can offer support and information on rare diseases.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.